Clinical Oncology
Volume 22, Issue 2 , Pages 153-154 , March 2010

Synchronous Ovarian Cancer in a Patient with Pleomorphic Lobular Breast Cancer: A Therapeutic Dilemma

References 

  1. Moule R, Sohaib A, Eeles R. Dramatic response to platinum in a patient with cancer with a germline BRCA2 mutation. Clin Oncol (R Coll Radiol). 2009;21:444–447
  2. Rhiem K, Wappenschmidt B, Bosse K, Köppler H, Tutt AN, Schmutzler RK. Platinum sensitivity in a BRCA1 mutation carrier with advanced breast cancer. Clin Oncol (R Coll Radiol). 2009;21:448–450
  3. Bristow RE, Eisenhauer EL, Santillan A, Chi DS. Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction. Gynecol Oncol. 2007;104:480–490
  4. Ries LM, Fenton MA, Dizon DS, et al. Neoadjuvant q4week carboplatin and weekly paclitaxel+trastuzumab in resectable and locally advanced breast cancer: a Brown University Oncology Group (BrUOG) study. J Clin Oncol. 2005;23:759;[abstract]
  5. Perez-Gracia JL, Carrasco EM. Tamoxifen therapy for ovarian cancer in the adjuvant and advanced settings: systematic review of the literature and implications for future research. Gynecol Oncol. 2002;84:201–209
  6. Gourley C, Smyth JF, Mackean M, et al. Phase II study of letrozole in estrogen receptor (ER) positive relapsed epithelial ovarian cancer (EOC). J Clin Oncol. 2006;24:5025;[abstract]
  7. Guastalla JP, Allouache D, Combe M, et al. HER2 overexpression and amplification in advanced ovarian cancer (AOC): treatment with trastuzumab – a GINECO study. J Clin Oncol. 2007;25:5559;[abstract]
  8. Orvieto E, Maiorano E, Bottiglieri L, et al. Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution. Cancer. 2008;113:1511–1520
  9. Mahtani RL, Vogel CL. Pleomorphic lobular carcinoma of the breast: four long-term responders to trastuzumab – coincidence or hint?. J Clin Oncol. 2008;26:5823–5824

PII: S0936-6555(09)00325-2

doi: 10.1016/j.clon.2009.09.025

Clinical Oncology
Volume 22, Issue 2 , Pages 153-154 , March 2010

Article Tools